Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 83
12
Diseases
10
Unique genes
0.299
Avg. similarity score
Ankylosis
Most-connected disease (7 links)
Disease
Searched: Antley-bixler syndrome
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Antley-bixler syndrome
Ankylosis
Beare-stevenson cutis gyrata syndrome
Cutis gyrata syndrome
Biliary tract neoplasms
Congenital aural atresia
Crouzon syndrome
Pfeiffer syndrome
Cardiofacial dysplasia
Congenital external auditory canal atresia
P450 oxidoreductase deficiency
craniosynostosis 4
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Ankylosis | 7 | 7 | 1 |
| Beare-stevenson cutis gyrata syndrome | 7 | 7 | 1 |
| Cutis gyrata syndrome | 7 | 7 | 1 |
| Biliary tract neoplasms | 6 | 6 | 3 |
| Congenital aural atresia | 6 | 6 | 2 |
| Antley-bixler syndrome | 5 | 5 | 3 |
| Crouzon syndrome | 5 | 5 | 2 |
| Pfeiffer syndrome | 3 | 3 | 3 |
| Cardiofacial dysplasia | 1 | 1 | 2 |
| Congenital external auditory canal atresia | 1 | 1 | 1 |
| P450 oxidoreductase deficiency | 1 | 1 | 1 |
| craniosynostosis 4 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| FGFR2 | 8 / 12 | Ankylosis, Antley-bixler syndrome, Beare-stevenson cutis gyrata syndrome, Biliary tract neoplasms and 4 more |
| ERF | 2 / 12 | craniosynostosis 4, Crouzon syndrome |
| POR | 2 / 12 | Antley-bixler syndrome, P450 oxidoreductase deficiency |
| PRKACB | 2 / 12 | Biliary tract neoplasms, Cardiofacial dysplasia |
| TSHZ1 | 2 / 12 | Congenital aural atresia, Congenital external auditory canal atresia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| CREB1 phosphorylation through the activation of Adenylate Cyclase | Reactome | 2 / 7 | 343× | 1.31e-5 | 4.08e-4 ✓ sig. |
| HDL assembly | Reactome | 2 / 8 | 300× | 1.74e-5 | 5.20e-4 ✓ sig. |
| Ras signaling pathway | KEGG | 4 / 237 | 20.3× | 2.83e-5 | 7.78e-4 ✓ sig. |
| Calcium signaling pathway | KEGG | 4 / 254 | 18.9× | 3.71e-5 | 9.72e-4 ✓ sig. |
| MAPK signaling pathway | KEGG | 4 / 299 | 16.1× | 7.02e-5 | 1.64e-3 ✓ sig. |
| Rap1 signalling | Reactome | 2 / 16 | 150× | 7.44e-5 | 1.71e-3 ✓ sig. |
| Regulation of insulin secretion | Reactome | 2 / 16 | 150× | 7.44e-5 | 1.71e-3 ✓ sig. |
| PKA activation in glucagon signalling | Reactome | 2 / 17 | 141× | 8.43e-5 | 1.90e-3 ✓ sig. |
| Parathyroid hormone synthesis, secretion and action | KEGG | 3 / 115 | 31.3× | 9.77e-5 | 2.15e-3 ✓ sig. |
| DARPP-32 events | Reactome | 2 / 19 | 126× | 1.06e-4 | 2.29e-3 ✓ sig. |
| PKA activation | Reactome | 2 / 19 | 126× | 1.06e-4 | 2.29e-3 ✓ sig. |
| CD209 (DC-SIGN) signaling | Reactome | 2 / 21 | 114× | 1.30e-4 | 2.69e-3 ✓ sig. |
| Oncogene Induced Senescence | Reactome | 2 / 33 | 72.8× | 3.25e-4 | 5.61e-3 ✓ sig. |
| FCGR3A-mediated IL10 synthesis | Reactome | 2 / 35 | 68.6× | 3.66e-4 | 6.17e-3 ✓ sig. |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | Reactome | 2 / 36 | 66.7× | 3.87e-4 | 6.46e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | GO:0035607 | 2 / 2 | 1,869× | 2.58e-7 | 2.68e-5 ✓ sig. |
| orbitofrontal cortex development | GO:0021769 | 2 / 3 | 1,246× | 7.73e-7 | 6.69e-5 ✓ sig. |
| ventricular zone neuroblast division | GO:0021847 | 2 / 3 | 1,246× | 7.73e-7 | 6.69e-5 ✓ sig. |
| positive regulation of phospholipase activity | GO:0010518 | 2 / 4 | 934× | 1.55e-6 | 1.19e-4 ✓ sig. |
| vascular endothelial cell response to laminar fluid shear stress | GO:0097700 | 2 / 9 | 415× | 9.26e-6 | 4.96e-4 ✓ sig. |
| lung-associated mesenchyme development | GO:0060484 | 2 / 9 | 415× | 9.26e-6 | 4.96e-4 ✓ sig. |
| high-density lipoprotein particle assembly | GO:0034380 | 2 / 10 | 374× | 1.16e-5 | 5.88e-4 ✓ sig. |
| regulation of protein processing | GO:0070613 | 2 / 11 | 340× | 1.41e-5 | 6.90e-4 ✓ sig. |
| chordate embryonic development | GO:0043009 | 2 / 11 | 340× | 1.41e-5 | 6.90e-4 ✓ sig. |
| branching involved in salivary gland morphogenesis | GO:0060445 | 2 / 12 | 311× | 1.70e-5 | 7.93e-4 ✓ sig. |
| mesenchymal cell differentiation | GO:0048762 | 2 / 13 | 287× | 2.00e-5 | 9.06e-4 ✓ sig. |
| regulation of osteoblast differentiation | GO:0045667 | 2 / 17 | 220× | 3.49e-5 | 1.38e-3 ✓ sig. |
| renal water homeostasis | GO:0003091 | 2 / 19 | 197× | 4.39e-5 | 1.64e-3 ✓ sig. |
| middle ear morphogenesis | GO:0042474 | 2 / 22 | 170× | 5.92e-5 | 2.05e-3 ✓ sig. |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 2 / 26 | 144× | 8.32e-5 | 2.65e-3 ✓ sig. |